Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

tACS for neuropathic pain after spinal cord injury

Official title: tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments

Run by The University of Texas Health Science Center, Houston · NCT06029075 · Data updated 2026-11-12

Researchers are testing whether transcranial alternating current stimulation (tACS) can help manage neuropathic pain in people who have had a spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment14 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 30, 2027
Study endsMarch 31, 2028
Registry record updatedJune 3, 2026
Trial IDNCT06029075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 with chronic neuropathic pain after SCI (or similar injuries) who are stable on pain medications for at least two weeks.

Probably not a fit

Individuals with non-neuropathic pain, recent changes in pain meds, or certain implants may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests different tACS settings to see if they reduce neuropathic pain in adults with spinal cord injury. Participants will be assigned to sham stimulation, 10 Hz tACS, or 20 Hz tACS to compare pain outcomes. The trial will start with SCI patients and may expand to other populations if feasible. Eligible participants are adults ages 18–75 with chronic neuropathic pain lasting more than 3 months who are stable on oral pain medications. Key exclusions include non-neuropathic pain, pacemakers or implants, arm amputations, inability to follow commands, or recent changes in pain therapy.

Why it matters

Potential benefit: If successful, participants could experience reductions in neuropathic pain and improved quality of life.

How similar studies have gone: Previous neuromodulation studies show potential for pain relief, but results for tACS in this context are exploratory and results have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion/exclusion criteria for SCI subjects

Inclusion criteria: A patient who

1. has neuropathic pain after traumatic spinal cord injury or amputation or brain injury;
2. has chronic pain, \>3 months;
3. is between 18 to 75 years of age;
4. is stable on oral pain medications at least two weeks. Patients are allowed to continue their pain medications, i.e., no change in pain medications.

NOTE: we plan to begin the study with the spinal cord injury (SCI) subject population as a cohort first, then expand to other subject populations

Exclusion criteria: Patients will be excluded if they

1. are currently adjusting oral pain medications for their neuropathic pain;
2. have pain, but not neuropathic, e.g., from inflammation at the incision wound of the residual limb or neuroma;
3. have a pacemaker metal implants or supplemental oxygen;
4. have amputation in their arm(s);
5. fail to have a motor contraction in the arm muscles with TMS;
6. are not able to follow commands, or to give consent;
7. have asthma or other pulmonary disease;
8. are not medically stable;
9. have preexisting psychiatric disorders;
10. alcohol or drug abuse.

Where it's running

  • The University of Texas Health Science Center
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Sheng Li, MD, Ph.D — The University of Texas Health Science Center, Houston
  • Study coordinator: Sheng Li, MD, Ph.D
  • Email: sheng.li@uth.tmc.edu
  • Phone: (713) 797-7125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.